LOGO
LOGO

Quick Facts

Varian Says Dow Wilson To Succeed Timothy Guertin As CEO - Quick Facts

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Varian Medical Systems (VAR) announced that Timothy Guertin has declared his intention to retire as the company's president and chief executive officer, or CEO, at the end of its current fiscal year on September 28, 2012. Executive vice president and chief operating officer Dow Wilson will succeed Guertin.

In addition, Varian's board of directors appointed Guertin as its vice chairman and appointed Wilson to the board, both effective as of September 29, 2012. Guertin will continue as a non-executive employee of the company until his retirement in February 2013.

Wilson joined Varian in 2005 as president of Oncology Systems where he doubled the business by expanding services, introducing Varian's technology-leading TrueBeam and RapidArc products for radiotherapy and radiosurgery, and pushing strongly into emerging international markets. He assumed responsibility for all of Varian's businesses upon his appointment as chief operating officer in October of 2011. He came to Varian from GE where he filled many management positions over his 20 year career there, including CEO of the $2.5 billion GE Healthcare-Information Technologies business.

Besides, Varian announced that Erich Reinhardt, former president and CEO of Siemens Healthcare, was appointed to the board effective August 10, 2012.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19